Health Catalyst, Inc.

HCAT Healthcare Health Information Services

Health Catalyst, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $311.1 million, up 1.48% from fiscal 2024.

Revenue
−26.3%
EPS
+268.8%
Free cash flow
+65.6%
Total debt
+0.29%

Quarter to September 2026, against a year earlier

1.47 0.03 −2.00%
Market cap
$112.9M
P/E
0.0×
Fwd P/E
−0.7×
Dividend yield
—
F-score
5/9
Altman Z
−3.66
Beneish M
−3.95
Dividend safety
n/a

Health Catalyst, Inc. (HCAT) P/E ratio

Alert me on P/E ratio

Health Catalyst, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 0.0× —
FY2018 0.0× —
FY2017 0.0× —

Quarterly newest first

Period P/E ratio Change
Sep 2026 0.0× —
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
28 more quarters

Against its own ten years

Low 0.0× High 0.0×
Ten-year median 0.0×
Current reading's percentile 100

P/E ratio against peers

Company P/E ratio
SY So-Young International Inc. Sponsored ADR compare n/m
DH Definitive Healthcare Corp. compare n/m
LFMD LifeMD, Inc. compare n/m
HCAT Health Catalyst, Inc. n/m
AMWL American Well Corporation compare n/m
CTEV Claritev Corporation compare n/m
SPOK Spok Holdings, Inc. compare 13.1×
CCLD CareCloud, Inc. compare 17.8×
OPRX OptimizeRx Corp. compare 36.3×
Health Information Services industry median 41.0×
Healthcare sector median 24.5×
Market median 17.8×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on HCAT